DAZAP1 Activators comprise a spectrum of chemical entities that indirectly augment DAZAP1's functional capacity within various cellular contexts, particularly concerning its role in RNA metabolism. Forskolin and Rolipram exert their effects by elevating cAMP levels, with Forskolin directly activating adenylate cyclase and Rolipram inhibiting phosphodiesterase 4, thus preventing cAMP degradation. The resultant elevated cAMP levels activate PKA, which may phosphorylate proteins that interface with DAZAP1, thereby enhancing DAZAP1's RNA-binding and regulatory functions. Ionomycin and A23187, both calcium ionophores, increase intracellular calcium, which could activate calcium-dependent kinases and phosphatases, potentially affecting DAZAP1's function in mRNA transport and stabilization. Phorbol 12-myristate 13-acetate (PMA) activates PKC, which may phosphorylate substrates that interact with DAZAP1, influencing its role in RNA splicing and export. Okadaic acid, a protein phosphatase inhibitor, sustains the phosphorylation of proteins that could include DAZAP1 interactants, potentially enhancing DAZAP1's involvement in mRNA processing.
Additional DAZAP1 activators like 8-Br-cAMP, a cAMP analog, and epigallocatechin gallate (EGCG), a kinase inhibitor, could fine-tune cellular signaling to favor DAZAP1-mediated pathways. 8-Br-cAMP activates PKA, leading to a potential increase in phosphorylation of DAZAP1-associated proteins, while EGCG might suppress competitive kinase signaling, indirectly facilitating DAZAP1's mRNA regulatory functions. Sphingosine-1-phosphate initiates a cascade via G-protein-coupled receptors that can intersect with pathways involving RNA-binding proteins like DAZAP1. PI3K inhibitors LY294002 and Wortmannin may shift intracellular signaling, indirectly potentiating DAZAP1's role in post-transcriptional gene regulation. Lastly, Thapsigargin, by inhibiting the SERCA pump, leads to elevated cytosolic calcium that might influence DAZAP1's function in mRNA editing and stability through calcium-dependent signaling pathways. Collectively, these compounds, through their targeted molecular effects, facilitate the enhancement of DAZAP1's biological activities.
SEE ALSO...
Items 11 to 20 of 20 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $74.00 $243.00 $731.00 $2572.00 $21848.00 | 53 | |
Intercalates in DNA and might inhibit RNA polymerase, thereby decreasing TMEM145 mRNA synthesis. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
A23187 is a calcium ionophore that raises intracellular calcium levels, which may activate calcium-dependent kinases and phosphatases, influencing DAZAP1's interaction with mRNA. | ||||||
RG 108 | 48208-26-0 | sc-204235 sc-204235A | 10 mg 50 mg | $131.00 $515.00 | 2 | |
Non-nucleoside DNA methyltransferase inhibitor, which may affect the methylation and expression of TMEM145. | ||||||
8-Bromoadenosine 3′,5′-cyclic monophosphate | 23583-48-4 | sc-217493B sc-217493 sc-217493A sc-217493C sc-217493D | 25 mg 50 mg 100 mg 250 mg 500 mg | $108.00 $169.00 $295.00 $561.00 $835.00 | 2 | |
8-Bromoadenosine 3',5'-cyclic monophosphate is a cell-permeable cAMP analog that activates PKA, which could phosphorylate proteins involved in the mRNA metabolism processes regulated by DAZAP1. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
EGCG is a kinase inhibitor that may reduce competitive signaling pathways, allowing for the enhancement of pathways that DAZAP1 is involved in, particularly in mRNA binding and regulation. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $133.00 $275.00 | 37 | |
Histone deacetylase inhibitor that could alter chromatin structure and TMEM145 gene expression. | ||||||
Chaetocin | 28097-03-2 | sc-200893 | 200 µg | $126.00 | 5 | |
Histone methyltransferase inhibitor that could affect histone methylation status and gene expression. | ||||||
D-erythro-Sphingosine-1-phosphate | 26993-30-6 | sc-201383 sc-201383D sc-201383A sc-201383B sc-201383C | 1 mg 2 mg 5 mg 10 mg 25 mg | $165.00 $322.00 $570.00 $907.00 $1727.00 | 7 | |
D-erythro-Sphingosine-1-phosphate acts through G-protein-coupled receptors to activate signaling cascades that could converge on pathways modulating RNA-binding proteins, including DAZAP1. | ||||||
Disulfiram | 97-77-8 | sc-205654 sc-205654A | 50 g 100 g | $53.00 $89.00 | 7 | |
Can inhibit the proteasome, potentially affecting protein degradation and indirectly gene expression. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Modulates retinoic acid receptors, which could alter transcription factor activity and TMEM145 expression. | ||||||